Hepatitis B D006509

Related MeSH Hierarchy (4)

Diseases [C] » Infections [C01] » Communicable Diseases » Blood-Borne Infections » Hepatitis B

Diseases [C] » Infections [C01] » Virus Diseases » DNA Virus Infections » Hepadnaviridae Infections » Hepatitis B

Diseases [C] » Infections [C01] » Virus Diseases » Hepatitis, Viral, Human » Hepatitis B

Diseases [C] » Digestive System Diseases [C06] » Liver Diseases » Hepatitis » Hepatitis, Viral, Human » Hepatitis B

Description

INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.   MeSH

Hierarchy View

Subtype Terms (1)

Hepatitis B, Chronic
171 drugs (45 approved, 126 experimental)



Organization Involved with Phase 4 Indications (231)

Aarhus University

Ajou University

Alaska Native Tribal Health Consortium

Asian Institute Of Medical Sciences

Asian-Pacific Alliance of Liver Disease, Beijing

Azad University

Baqiyatallah Medical Sciences University

Baylor University

Beijing Kawin Technology Share-Holding Co., Ltd.

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Bukwang Pharmaceutical

Burroughs Wellcome

Calmette Hospital

Cangene

Capital Medical University

Case Western Reserve University

Catholic University of Korea

Centers for Disease Control and Prevention (CDC)

Centers for Disease Control and Prevention, China

Centre for Infectious Disease Research in Zambia (CIDRZ)

Chang Gung University

Changhua Christian Hospital

Changi General Hospital

ChengChing Hospital

Chiangmai University

Chiayi Christian Hospital

Children's National Medical Center

Chimei Medical Center

China Academy of Chinese Medical Sciences

China Medical University

Chinese Academy of Medical Sciences

Chinese University of Hong Kong

Chonbuk National University

Chong Kun Dang Pharmaceutical

Chongqing Medical University

Chung-Ang University

Chungbuk National University

Chungnam National University

Chung Shan Medical University

City University of Hong Kong

Columbia University

C&R Research, Inc.

Crucell

Daegu Catholic University

Daewoong Pharmaceutical Co. LTD.

Dalin Tzu Chi General Hospital

Department of Health, United Kingdom

DePaul University

Dong-A Pharmaceutical

Dong-A University

Dongguk University

Erasmus University Rotterdam

Eulji University

Far Eastern Memorial Hospital

Federal University of Goias

Fifth Hospital of Shijiazhuang City

First People's Hospital of Foshan

First People's Hospital, Shunde China

Fonds NutsOhra

Foundation for Liver Research

French National Agency for Research on AIDS and Viral Hepatitis

Fudan University

Fu Jen Catholic University

Fujian Cosunter Pharmaceutical Co. Ltd

Gachon University

Genematrix Inc.

Georgetown University

GlaxoSmithKline

Gottfried Wilhelm Leibniz Universität Hannover

Government of China

Government of Singapore

Government of Taiwan

Govind Ballabh Pant Institute of Postgraduate Medical Education and Research

Guangxi Medical University

Guangzhou University

Guizhou Medical University

Hallym University

Hanmi Pharmaceutical

Hannover Clinical Trial Center GmbH

Hanyang University

Hebei Medical University

Hebei University

Hebrew University

Henan Medical University

Hepatobiliary Disease Hospital of Jilin Province, Jilin, China

HIV-NAT Thai Red Cross AIDS Research Center

Huai'an No. 4 People's Hospital

Huazhong University of Science and Technology

Hubei University of Chinese Medicine

Huizhou People's Central Hospital

Humanity & Health Research Centre

Icahn School of Medicine at Mount Sinai

IlDong Pharmaceutical Co Ltd

Inha University

Inje University

Instituto de Estudios de Ciencias de la Salud de Castilla y León (IECSCYL)

Institut Pasteur

International Antiviral Therapy Evaluation Center (IATEC)

I-Shou University

J. Craig Venter Institute

Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd

Jiao Tong University

Kangbuk Samsung Hospital

Kaohsiung Medical University

Keimyung University

King Abdul-Aziz University

Konkuk University

Korea University

Kunming Medical University

Kyung Hee University

Kyungpook University

Laval University

LG

Liaocheng People's Hospital

Linyi People's Hospital

Luohe Central Hospital

Major Science and Technology Special Project of China Twelfth-Five-Year Project

Makerere University

McMaster University

Merck

Mercy Medical Center

Monash University

Nanchang University

Nanhua Hospital

Nanjing Medical University

Nanyang Central Hospital

Nanyang Technological University

National Cheng Kung University

National Guard Health Affairs

National Health and Family Planning Commission, P.R.China

National Institute of Mental Health (NIMH)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute on Drug Abuse (NIDA)

National Taiwan University

National University of Singapore

New Discovery LLC

New York University

Ningxia Medical University

Novartis

Ohio State University

Peking University

People's Liberation Army of China

Pfizer

Pontificia Universidad Catolica de Chile

Public Health England

Pusan National University

Qidong Liver Cancer Institute

Qingdao Infectious Diseases Hospital

Qingdao University

Roche

Rush University

RWTH Aachen University

Sanofi

SciClone Pharmaceuticals

Scripps

Second Military Medical University

Seoul National University

Shandong University of Traditional Chinese Medicine

Shanghai Medical University

Shanghai University

Shanghai University of Traditional Chinese Medicine

Shantha Biotechnics Limited

Shantou University

Shanxi Medical University

Shenzhen Kangtai Biological Products Co., LTD

Shenzhen Third People's Hospital

Shineway Pharmaceutical Co.,Ltd

Sichuan University

Singapore Clinical Research Institute

Singapore General Hospital

Sinovac Biotech Co., Ltd

SmithKline Beecham

Soonchunhyang University

Southeast University

Southern Medical University

Stanford University

St. Jude Children's Hospital

St. Martin De Porress Hospital

Sungkyunkwan University

Sun Yat-Sen University

Tai'an Central Hospital

Taichung Veterans General Hospital

Taipei Medical University

Taipei Veteran General hospital

The American Society of Tropical Medicine and Hygiene

The Fifth Hospital of Shijiazhuang

The Fifth People's Hospital of Suzhou

The Third Hospital of Qinhuangdao City

The Third People's Hospital of Taiyuan

The University of Hong Kong

Thomas Jefferson University

Tulane University

Tung's Taiching MetroHarbor Hospital

Tzu Chi University

Uganda Cancer Institute

University of Amsterdam

University of Bern

University of British Columbia

University of California, San Diego

University of California, San Francisco

University of Kinshasa

University of London

University of Maryland

University of Miami

University of New South Wales

University of North Carolina at Chapel Hill

University of Oxford

University of Paris

University of Salamanca

University of South Florida

University of Toronto

University of Ulm

University of Ulsan

University of Washington

University of Western Ontario

University of Wisconsin

Vanderbilt University

VBI Vaccines Inc.

ViiV Healthcare

Weifang People's Hospital

Weizmann Institute of Science

Wenzhou Medical University

Xinjiang Medical University

Yale University

Yeshiva University

Yeungnam University

Yonsei University

Yuebei People's Hospital

Yung Shin Pharm. Ind. Co., Ltd.

Zhejiang Hisun Pharmaceutical Co. Ltd.

Zhejiang University

Organization Involved with Phase 3 Indications (68)

Organization Involved with Phase 2 Indications (107)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.